Reporting a Regenerative Medicine Side Effect (FDA Guide)

By the Regenerative Evidence Guide Team

What Counts as a Regenerative Medicine Side Effect or Product Concern?

If you had a regenerative-medicine procedure — such as a stem cell injection, platelet-rich plasma (PRP) treatment, or an exosome product — and something felt wrong afterward, you may not know where to turn. This guide explains the difference between a medical emergency and a reportable safety concern, and walks through the official U.S. government channel for reporting problems with these products.

This page does not diagnose your symptoms or tell you whether your reaction is serious. It gives you a clear next step so you can get the right kind of help.

Is This a Medical Emergency? Check These Signs First

Some reactions after a regenerative-medicine procedure need immediate medical attention. Call 911 or go to the nearest emergency room right away if you notice:

• Sudden vision changes or loss of vision
• Signs of a serious infection, such as spreading redness, fever, chills, or pus at the injection or collection site
• New weakness, numbness, confusion, or trouble speaking
• Severe or worsening pain, swelling, or shortness of breath
• Any symptom that feels sudden, severe, or rapidly getting worse

Reporting a regenerative medicine product problem to the government comes after you are medically safe. A federal report is not a substitute for emergency or follow-up care from a clinician.

Do You Report a Concern or See a Doctor First? Both — Here’s the Difference

It helps to keep these two steps separate:

• Getting care means seeing a doctor or emergency provider about your symptoms. This guide does not replace that step.
• Reporting a concern means telling the U.S. Food and Drug Administration (FDA) what happened, so the product or clinic can be reviewed. This is a separate, voluntary action you can take once you are safe.

You can report a regenerative medicine side effect even if your symptoms were mild, and even if you already saw a doctor.

If This, Then That: A Quick Decision Path

1. If your symptoms are severe or getting worse right now — call 911 or go to the emergency room. Report to the FDA afterward, once you’re safe.
2. If your symptoms are mild and started recently — contact your treating provider, then consider filing a MedWatch report so the FDA has a record.
3. If your symptoms started weeks or months after treatment — a delayed onset doesn’t rule out a connection to the product. The FDA has documented delayed complications, including tumor formation, from unapproved regenerative products. Reporting is still worthwhile.
4. If you’re not sure the product caused your symptoms — you can still file a report. The FDA’s consumer information invites reports from anyone treated with these products who wants to report an adverse effect or file a complaint; it does not ask you to first prove a cause.

Myth vs. Reality: Reporting a Regenerative Medicine Concern

• Myth: “Only doctors can file a safety report.”
  Reality: The FDA’s MedWatch program receives reports directly from the public, not only from health professionals.
• Myth: “If the clinic says the product is FDA-registered, it must be approved.”
  Reality: The FDA has stated that a company registering with the agency, or a study appearing on ClinicalTrials.gov, does not mean the product itself is legally marketed for that use.
• Myth: “Reporting only matters for prescription drugs.”
  Reality: The FDA’s reporting system covers a wide range of regulated products, including biologics such as human cells and tissue-based products — the category that covers many stem cell and regenerative offerings.
• Myth: “If I didn’t get sick right away, there’s nothing to report.”
  Reality: The FDA has documented delayed complications from unapproved regenerative products, including tumor formation and cells traveling to unintended parts of the body.

What Has the FDA Documented About Regenerative Medicine Product Risks?

The FDA has published a consumer warning about unapproved regenerative medicine products — including those described as stem cells, stromal vascular fraction, cord blood-derived cells, amniotic fluid products, Wharton’s jelly products, and exosomes. According to the FDA, it has received reports connected to these unapproved products involving:

• Blindness
• Tumor formation
• Neurological events
• Bacterial infections, including serious bloodstream infections
• Unwanted inflammatory or immune reactions
• Cells moving to another part of the body and forming unintended tissue growth
• Cross-contamination during processing with bacteria, viruses, or mold

The FDA also notes that, aside from certain cord blood-derived products approved for specific blood-related conditions, most stem cell products on the market have not been approved to treat conditions such as arthritis, chronic pain, neurological disease, or heart or lung disease. This is an important evidence limit: a product being widely marketed for regenerative purposes does not mean it has been proven safe or effective for that use.

Where Do You Send a Regenerative Medicine Safety Report?

The FDA runs a program called MedWatch specifically for reporting safety problems with regulated medical products, including biologics that cover many regenerative-medicine offerings. You can reach it a few ways, and using more than one is fine if you’re unsure which fits your situation.

1. File a MedWatch report online through the FDA’s official reporting portal.
2. Call the FDA at 1-888-INFO-FDA (1-888-463-6332) if you’d rather report by phone.
3. If the product was marketed specifically as a regenerative medicine therapy — such as stem cells or exosomes — offered outside of an FDA-supervised clinical trial, also contact the FDA’s Office of Compliance and Biologics Quality directly by email, in addition to filing a MedWatch report.

What to Gather Before You File a Report

Having a few details ready can make the reporting process faster. Before you start, try to write down:

• The name of the product or procedure, exactly as it was described to you
• The name and location of the clinic or provider
• The date of the procedure and the date your symptoms started
• A plain description of what happened, in the order it happened
• Any paperwork, consent forms, receipts, or marketing material you were given
• Names of any other medical providers who treated you afterward

You are not required to have all of this information. Report what you know, and note anything you’re unsure about.

What Should You Ask Before Your Next Appointment?

If you plan to follow up with a doctor about what happened, or you are deciding whether to pursue another regenerative-medicine procedure, these questions can help guide that conversation. For background on how this publication weighs claims like these, see How We Research.

• Is this product FDA-approved for my specific condition, or is it being offered outside of an approved use?
• Is this procedure part of an FDA-supervised clinical trial? If so, can I see the trial registration?
• What has been documented about risks specific to this exact product, not regenerative medicine in general?
• What would follow-up monitoring look like if I go forward?
• Where would I report a problem if one came up later?

Frequently Asked Questions

Who can file a MedWatch report about a regenerative medicine product?

Patients and consumers can file reports directly — you don’t need a doctor to submit it on your behalf. The FDA’s MedWatch program receives reports from the general public as well as from health professionals.

Does FDA registration mean a regenerative medicine product is approved?

No. The FDA has stated that a company registering with the agency, or a study being listed on ClinicalTrials.gov, does not mean the product is legally marketed. Some clinics reference these listings to suggest legitimacy that isn’t actually there.

What products are covered by this reporting system?

MedWatch covers a broad range of FDA-regulated products, including biologics such as blood components, gene therapies, and human cells and tissue-based products — the category many stem cell and regenerative offerings fall under — along with prescription and over-the-counter medicines and medical devices.

Do I have to choose between seeing a doctor and reporting to the FDA?

No. These are two separate actions. Seeing a doctor addresses your symptoms directly. Filing a report with the FDA adds your experience to a safety-monitoring system that can prompt further review of a product or clinic. You can do both.

What if I received the product outside the U.S. or through a foreign clinic?

This guide covers the FDA’s reporting pathway, which applies to products marketed or used in the United States. If your procedure happened entirely outside the U.S. through a non-U.S. provider, the FDA reporting channels described here may not apply to your case, and you may need to look into that country’s equivalent regulatory agency.

What This Page Cannot Tell You

This guide cannot tell you whether your specific symptoms are related to a specific product, whether you should pursue legal action, or what your treatment should be. Those questions depend on your individual medical history and should go to a qualified clinician. The role of this page is limited to explaining the official government reporting pathway and helping you organize the facts.

Related Reading on This Site

• Start Here — an overview of how to evaluate regenerative-medicine claims and where this site’s guides fit together.
• Editorial Policy — how this publication decides what to cover and how corrections are handled.
• Medical Information Disclaimer — the full scope and limits of the medical information on this site.

Sources

• U.S. Food and Drug Administration, “MedWatch: The FDA Safety Information and Adverse Event Reporting Program”
• U.S. Food and Drug Administration, “Important Patient and Consumer Information About Regenerative Medicine Therapies”

Medical Information Disclaimer

This article is for general educational purposes only and is not medical advice. It does not diagnose conditions, recommend treatment, or replace care from a licensed healthcare provider. If you are experiencing a medical emergency, call 911 or go to the nearest emergency room. Regenerative Evidence Guide is an independent educational publication and is not affiliated with the former academy, faculty, conferences, clinics, or training programs previously associated with this domain.

By Regenerative Evidence Guide Editorial Team. Last updated September 8, 2026.